Entering text into the input field will update the search result below

ABSI Absci Corporation
Stock Price & Overview

$1.650.02 (+1.23%)3:15 PM 11/30/23
NASDAQ | $USD | Realtime

Charts

FFO (FWD)
PE
Div Rate (TTM)
Yield (TTM)
Short Interest
Market Cap
Volume
Prev. Close

Quant Ranking

Ratings Summary

SA Analysts
Wall Street
Quant
Now3M ago6M ago
Valuation
-Rating: Not Covered
Growth
-Rating: Not Covered
Profitability
-Rating: Not Covered
Momentum
-Rating: Not Covered
Revisions
-Rating: Not Covered

See ABSI ratings with Premium.

People Also Follow

Company Profile

Absci Corporation logo
Absci Corporation operates as a generative AI drug creation company in the United States. Its integrated drug creation platform identifies novel drug targets and creates biotherapeutic candidates. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Employees
193
Founded
2011
Address
  • 18105 SE Mill Plain Boulevard
  • Vancouver, WA, 98683
  • United States
Phone Number
360 949 1041
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.